Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and PK/PD of HSK36273 anticoagulation in patients undergoing continuous renal replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Renal Replacement Therapy-related Conditions

Drugs mentioned

• HSK36273

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Renal Replacement Therapy | Phase 2 | Status: UNKNOWN